Literature DB >> 16002021

Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers.

Hendree E Jones1, Conrad J Wong, Michelle Tuten, Maxine L Stitzer.   

Abstract

This controlled study examined the efficacy of reinforcement-based therapy (RBT) for producing enhanced abstinence outcomes over 12 months in opioid-dependent patients exiting a brief residential detoxification. Patients were randomly assigned upon completing their medically managed taper (i.e., detoxification) to RBT (N=66) or usual care (N=64) referral to community treatment programs. The 6-month RBT program offered an array of abstinence-based incentives including rent payment for recovery housing, program-led recreational activities and skills training for procuring employment. RBT produced significantly higher self-report and urinalysis-confirmed rates of abstinence from opioids and cocaine relative to usual care at 1 (42% versus 15%) and 3 (38% versus 17%) months during treatment but not at 6 or 12 months after enrollment. The RBT but not the usual care group showed significant increases in the number of days worked and the amount of legal income earned at 3, 6 and 12 months. The results of this randomized study suggest that an intensive reinforcement-based therapy that includes abstinence-based recovery housing is a promising approach; however, further research is needed to determine the role of treatment intensity and the specific efficacy of RBT's component parts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002021     DOI: 10.1016/j.drugalcdep.2005.01.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  19 in total

Review 1.  Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.

Authors:  Carla J Rash; Maxine Stitzer; Jeremiah Weinstock
Journal:  J Subst Abuse Treat       Date:  2016-09-28

2.  Addiction severity index composite scores as predictors for sexual-risk behaviors and drug-use behaviors in drug-using pregnant patients.

Authors:  R Chaudhury; H E Jones; W Wechsberg; K E O'Grady; M Tuten; M S Chisolm
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

3.  Adolescent Onset of Maternal Substance Abuse: Descriptive Findings from a Feasibility Trial.

Authors:  Lisa Saldana; Dana K Smith; Elisa Weber
Journal:  J Child Adolesc Subst Abuse       Date:  2013-11

4.  Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification.

Authors:  Michelle Tuten; Anthony DeFulio; Hendrée E Jones; Maxine Stitzer
Journal:  Addiction       Date:  2012-02-28       Impact factor: 6.526

5.  Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: results of an initial feasibility and efficacy randomized clinical trial.

Authors:  Michelle Tuten; Heather Fitzsimons; Margaret S Chisolm; Paul A Nuzzo; Hendree E Jones
Journal:  Addiction       Date:  2012-06-21       Impact factor: 6.526

Review 6.  A "SMART" design for building individualized treatment sequences.

Authors:  H Lei; I Nahum-Shani; K Lynch; D Oslin; S A Murphy
Journal:  Annu Rev Clin Psychol       Date:  2011-12-12       Impact factor: 18.561

7.  Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment.

Authors:  Hendrée E Jones; Kevin E O'Grady; Michelle Tuten
Journal:  Am J Addict       Date:  2011-03-08

8.  Intervention for homeless, substance abusing mothers: findings from a non-randomized pilot.

Authors:  Natasha Slesnick; Gizem Erdem
Journal:  Behav Med       Date:  2012       Impact factor: 3.104

9.  Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.

Authors:  Nancy M Petry; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2013-03-25

Review 10.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.